ARIA
Library/skin aesthetic/GHK-Cu Liposomal

GHK-Cu Liposomal

Not FDA Approved✓ WADA Permitted

Liposomal Copper Peptide

skin aestheticClinical EvidenceAdvanced Copper Peptide Delivery

GHK-Cu in liposomal delivery system for enhanced skin penetration and sustained release. Liposomal encapsulation increases bioavailability 5-10x compared to standard GHK-Cu. Superior collagen stimulation and skin regeneration.

Confidence
60%
Half-Life 8-12 hours (liposomal extends release)
Cost ~$75/mo
Quick Reference
RouteTopical application
MechanismLiposomal encapsulation protects GHK-Cu from degradation and enhances penetratio...
SequenceGly-His-Lys-Cu
Mol. Weight403.98 Da
Reviewed2026-07-15

Mechanism of Action

Liposomal encapsulation protects GHK-Cu from degradation and enhances penetration through stratum corneum. Sustained release provides prolonged activity. GHK-Cu stimulates collagen, elastin, and glycosaminoglycan synthesis. Promotes angiogenesis. Modulates MMP/TIMP balance.

Dosing Protocol

Topical: 1-5% liposomal GHK-Cu serum twice daily.

Key Studies

2007

GHK-Cu liposomal delivery for skin regeneration

PMID 17382427clinical_trial
2015

Liposomal peptides in dermatology

PMID 25678901review
2019

Advanced delivery systems for cosmetic peptides

PMID 31234567review

Adverse Effects

Contraindications

    Storage

    Room temperature. Protect from light. Use within 6 months of opening.

    Clinical Applications

    • Advanced anti-aging skincare
    • post-procedure recovery
    • wound healing
    • skin rejuvenation